Feasibility of the Integrative Medication Self-Management Intervention to Promote Medication Adherence (IMedS)

University of Wisconsin, Milwaukee

Status and phase: Completed; Phase 1

Conditions: Chronic Disease; Medication Adherence

Treatments: Behavioral: Integrative Medication Self Management (IMedS) Intervention; Behavioral: Standard Care Educational Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT02706548

15.048

Details and patient eligibility

About

Many persons with chronic health conditions fail to take their medications as prescribed, resulting in declines in health and function. Unfortunately, current interventions for medication nonadherence are not very effective. This objective of this study is to test a new intervention, the Integrative Medication Self-management (IMedS) intervention to improve medication adherence in adults with chronic health conditions.

Full description

Many persons with chronic health conditions fail to take their medications as prescribed, resulting in declines in health and function. Objective: The purpose of this study was to perform a phase I feasibility study to understand if an integrated occupational therapy intervention could help people with chronic health conditions improve their adherence to medications. Method: Using a small-N design, we report single-subject analyses of the medication adherence, behavior counts, and perceptions of medication adherence of participants before and after either an occupational therapy intervention or standard of care intervention. We used a multiple baseline approach with inter-subject replication, and blinding.

Enrollment: 34 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with a chronic health condition
• Live in the community
• A medication regimen of 5 or more medications a day recommended by a health care professional
• Independently manage medications
• Difficulty taking medications as prescribed
• Live in the Milwaukee area

Exclusion criteria

• Significant cognitive impairment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

34 participants in 2 patient groups

Occupational Therapy Intervention Group

Experimental group

Description:

Thirty-minute intervention in which the participant and interventionist discuss past medication taking performance, medication-related goals, and strategies to meet goals. Intervention is enhanced with motivational interviewing and therapeutic use of self.

Treatment:

Behavioral: Integrative Medication Self Management (IMedS) Intervention

Standard Care Intervention Group

Active Comparator group

Description:

Thirty-minute educational intervention in which the participant and interventionist review a pamphlet on adherence to medication.

Treatment:

Behavioral: Standard Care Educational Intervention